Skip to main navigation Skip to search Skip to main content

Effect of Aspirin on Biomarkers of Barrett’s Esophagus After Successful Eradication with Radiofrequency Ablation

  • Robert S. Bresalier
  • , Nicholas J. Shaheen
  • , Mike Hernandez
  • , Navtej Buttar
  • , Norman Marcon
  • , Sachin Wani
  • , Raman Muthusamy
  • , Gary Falk
  • , Tamara Tipps Johnson
  • , Peiying Yan
  • , Xiaofang Huo
  • , Tawana A. Castille
  • , Gary Della’Zanna
  • , Ellen Richmond
  • , J. Jack Lee
  • , Powel Brown
  • , Rhonda Souza

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives/Methods: Placebo-controlled phase II study evaluated aspirin’s effect on CDX2 mRNA and prostanoid production in native and neosquamous epithelium after successful radiofrequency ablation (RFA) in Barrett’s esophagus. Results: At 12 months TXB2, PGF2α, PGD2, PGE2, PGE1, and α13PGE2 increased in native squamous but not neosquamous epithelium in individuals randomized to placebo. Aspirin use significantly reduced CDX2 mRNA in native squamous epithelium, and was associated with decreases in PGE1, PGE2 and 13PGE2 in neosquamous epithelium. Conclusions: After RFA, native squamous and neosquamous epithelium exhibit different molecular markers and responses to aspirin suggesting that different sources of squamous progenitors contribute to esophageal re-epithelization.

Original languageEnglish (US)
Pages (from-to)1034-1042
Number of pages9
JournalDigestive Diseases and Sciences
Volume70
Issue number3
DOIs
StatePublished - Mar 2025

Keywords

  • Barrett’s esophagus
  • CDX2
  • Chemoprevention
  • Eicosanoids
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Effect of Aspirin on Biomarkers of Barrett’s Esophagus After Successful Eradication with Radiofrequency Ablation'. Together they form a unique fingerprint.

Cite this